Morningstar

Enovis Corp ENOV

Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies

GlobeNewswire Sep 9, 2024 7:50pm
Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting

GlobeNewswire Sep 5, 2024 12:00pm
Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures

GlobeNewswire Aug 20, 2024 12:00pm
Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability

GlobeNewswire Aug 19, 2024 12:00pm
Enovis to Participate in Upcoming Investor Conferences

GlobeNewswire Aug 12, 2024 8:10pm
Enovis Announces Second Quarter 2024 Results

GlobeNewswire Aug 7, 2024 10:00am
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call

GlobeNewswire Jul 25, 2024 10:00am
Enovis to Host Second Quarter 2024 Results Conference Call on August 7th

GlobeNewswire Jul 16, 2024 11:00am
Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®

GlobeNewswire Jul 12, 2024 12:00pm
EQT to Sell LimaCorporate to Enovis

Global News Select Sep 25, 2023 12:02pm
Enovis to acquire implant maker LimaCorporate for 800 million euros in cash and stock

MarketWatch Sep 25, 2023 10:14am

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2024 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.